These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9221050)

  • 1. [Temporary changes and permanent changes in the erythrocyte blood-group antigens in malignant hemopathies].
    Hafner V; Coatmelec M; Niculescu R
    Rom J Intern Med; 1996; 34(3-4):183-8. PubMed ID: 9221050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
    Irvine AE; Magill MK; Somerville LE; McMullin MF
    Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of ABO blood groups in childhood acute leukemia.
    Alavi S; Ashraf H; Rashidi A; Hosseini N; Abouzari M; Naderifar M
    Pediatr Hematol Oncol; 2006 Dec; 23(8):611-7. PubMed ID: 17065136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A; Babusíková O
    Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
    Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of refractory anemia with excess of blasts (RAEB) having weakened expression of B blood group antigen].
    Munekata R; Miyazawa I; Matsuzaki H; Yoshino K; Hirano M; Mukôyama H; Nariuchi H
    Rinsho Ketsueki; 1990 Dec; 31(12):1960-4. PubMed ID: 2079733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia].
    Fujita A; Fujisawa S; Hyo R; Kuwabara H; Yamazaki E; Tomita N; Ishigatsubo Y
    Rinsho Ketsueki; 2008 Jan; 49(1):51-4. PubMed ID: 18277597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of carbonic anhydrase II in hematological malignancies.
    Leppilampi M; Koistinen P; Savolainen ER; Hannuksela J; Parkkila AK; Niemelä O; Pastoreková S; Pastorek J; Waheed A; Sly WS; Parkkila S; Rajaniemi H
    Clin Cancer Res; 2002 Jul; 8(7):2240-5. PubMed ID: 12114426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
    Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
    Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.